Sugarlo 50 Mg 30 Tablets

Sugarlo 50 Mg 30 Tablets

Description:

Sugarlo 50 mg 30 tablets is an oral anti-diabetic prescription medicine containing vildagliptin, a dipeptidyl peptidase-4 (dpp-4) inhibitor. It is used as part of a comprehensive diabetes care plan to help control blood glucose levels in adults with type 2 diabetes mellitus. Sugarlo works by increasing the levels of incretin hormones, which enhance insulin secretion and reduce glucagon release in a glucose-dependent manner, thereby improving glycemic control without usually causing significant weight gain. It is typically used in combination with diet, exercise, and sometimes other anti-diabetic medications as directed by a healthcare professional.

Indications:

• Management of type 2 diabetes mellitus in adults, particularly when diet and exercise alone do not provide adequate glycemic control.
• May be used as monotherapy in patients who cannot tolerate metformin or in whom metformin is contraindicated (as per physician’s decision).
• May be used as add-on therapy in combination with other oral anti-diabetic agents such as metformin, sulfonylureas, thiazolidinediones, or insulin to improve blood sugar control.
• Helps reduce elevated fasting and postprandial (after-meal) blood glucose levels.

Active Ingredients / Key Components:

• Vildagliptin – 50 mg per tablet.
• Excipients: The full list of inactive ingredients (excipients, coloring agents, preservatives) is not available in the provided information. Please refer to the package leaflet for complete composition.

Dosage & Administration / How to Use:

• Use only as prescribed by a physician experienced in the management of diabetes.
• Typical adult dose (general reference for vildagliptin 50 mg):
  – As monotherapy or in combination with some agents: often 50 mg once or twice daily, depending on the treatment regimen and combination (exact dose and schedule must be determined by the doctor).
  – Maximum total daily dose is usually 100 mg vildagliptin, but your doctor will decide the appropriate dose for you.
• Tablets are taken orally with water, with or without food. Taking it at the same time each day helps improve adherence.
• Do not crush or chew unless your doctor or pharmacist specifically advises otherwise.
• If you miss a dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Regular monitoring of blood glucose (and sometimes liver function tests and kidney function) is recommended during treatment.
• Always follow your doctor’s instructions regarding diet, exercise, and concurrent diabetes medications while using Sugarlo.

Clinical Benefits:

• Improves glycemic control in adults with type 2 diabetes by enhancing glucose-dependent insulin secretion and reducing inappropriate glucagon levels.
• Helps lower both fasting and postprandial blood glucose, supporting better long-term blood sugar management.
• Low intrinsic risk of hypoglycemia when used alone (monotherapy) or with agents that do not cause hypoglycemia, as its action is glucose-dependent.
• Generally weight-neutral, making it suitable for many patients concerned about weight gain associated with some other anti-diabetic medications.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to vildagliptin or any component of the formulation.
• Not indicated for the treatment of type 1 diabetes mellitus or for diabetic ketoacidosis.
• Use with caution in patients with moderate to severe renal impairment; dose adjustment or alternative therapy may be required as per physician guidance.
• Liver function abnormalities: vildagliptin has been associated with elevated liver enzymes in some patients. Periodic monitoring of liver function tests (lft) may be recommended. Discontinue if persistent elevations occur or if signs of liver disease appear.
• Pancreatitis risk: dpp-4 inhibitors, including vildagliptin, have been associated rarely with acute pancreatitis. If severe and persistent abdominal pain occurs, stop the medication and contact a doctor immediately.
• Use during pregnancy and breastfeeding: safety data are limited. Use only if clearly needed and prescribed by a healthcare professional after assessing risks and benefits.
• Inform your doctor about all other medications you are taking (including insulin, sulfonylureas, or other oral anti-diabetics) to reduce the risk of hypoglycemia and drug interactions.
• Alcohol intake should be moderated, as it can affect blood sugar control and may increase the risk of side effects.
• Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as liver disease, kidney disease, heart disease, pancreatitis, or a history of severe hypoglycemia.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects (may include, but are not limited to): headache, dizziness, mild gastrointestinal disturbances such as nausea, indigestion, or constipation.
• When used in combination with other anti-diabetic medicines (especially sulfonylureas or insulin), hypoglycemia (low blood sugar) may occur. Symptoms include sweating, tremor, hunger, palpitations, confusion, or dizziness.
• Possible liver enzyme elevations; rarely, signs of liver problems such as yellowing of the skin or eyes (jaundice), dark urine, or persistent fatigue may occur.
• Rare but serious: acute pancreatitis (severe, persistent abdominal pain, sometimes radiating to the back, with or without vomiting). Seek immediate medical attention if suspected.
• Allergic reactions such as rash, itching, or swelling of the face, lips, or tongue may occur in sensitive individuals. Stop use and seek urgent medical help if severe allergic symptoms develop.
• If any side effects are severe, persistent, or concerning, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Do not store above the temperature specified on the package (refer to carton for exact storage temperature if available).

Specifications:

• Product type: prescription anti-diabetic medicine (dpp-4 inhibitor).
• Strength: 50 mg vildagliptin per tablet.
• Form: film-coated tablet.
• Pack size: 30 tablets per pack.
• Intended use: adult patients with type 2 diabetes mellitus, as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.